We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

WMB:NYSEWilliams Companies, Inc. (The) Analysis

Data as of 2026-03-10 - not real-time

$73.18

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Williams Companies trades at $73.18, comfortably above its 20‑day SMA (73.03) and 50‑day SMA (66.91), confirming a short‑term bullish bias, but the MACD histogram is negative (‑0.33) and the signal line sits above the MACD line, signalling emerging bearish momentum. RSI sits at 59, indicating the stock is neither overbought nor oversold, while volume has been trending down, suggesting weakening participation as price approaches the near‑term support at $66.95. Valuation metrics are stretched: the forward P/E of 27.9 and current P/E of 34.2 far exceed the industry average of 20.6, and the DCF fair value of $43.59 implies the market is pricing a sizable premium.
Fundamentally, WMB posted 8.7% revenue growth, strong gross (62%) and operating margins (41%), and a dividend yield of 2.83% with a payout ratio near 94%, which raises sustainability concerns given negative free cash flow and a debt‑to‑equity ratio of 197. Recent analyst sentiment is positive – Scotiabank upgraded the outlook to “Sector Outperform” and the consensus remains a “Buy” with a median 12‑month target of $78, though the average target of $70.72 reflects a modest downside bias.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Negative MACD histogram indicating weakening momentum
  • Decreasing volume trend reducing short‑term liquidity
  • Price near technical support at $66.95

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Robust revenue growth and high operating margins
  • Attractive dividend yield despite sustainability concerns
  • Analyst upgrade to Sector Outperform and median price target of $78

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • High debt‑to‑equity ratio limiting financial flexibility
  • Valuation multiples well above industry peers
  • Dividend payout near 94% of earnings raising sustainability questions

Key Metrics & Analysis

Financial Health

Revenue Growth8.70%
Profit Margin22.13%
P/E Ratio34.2
ROE18.55%
ROA4.90%
Debt/Equity197.03
P/B Ratio7.0
Op. Cash Flow$5.9B
Free Cash Flow$-353500000
Industry P/E20.6

Technical Analysis

TrendBullish
RSI59.1
Support$66.95
Resistance$76.87
MA 20$73.03
MA 50$66.91
MA 200$61.49
MACDBearish
VolumeDecreasing
Fear & Greed Index75.89

Valuation

Fair Value$43.59
Target Price$77.41
Upside/Downside5.79%
GradeOvervalued
TypeBlend
Dividend Yield2.83%

Risk Assessment

Beta0.50
Volatility22.47%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.